Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,753Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 130JANSSEN PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7943582

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204353

Patent Use Code : U-493

Delist Requested :

Patent Use Description : TREATMENT OF TYPE 2 DI...

Patent Expiration Date : 2029-02-26

blank

02

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8513202

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204353

Patent Use Code : U-2441

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-03

blank

03

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8513202

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204353

Patent Use Code : U-493

Delist Requested :

Patent Use Description : TREATMENT OF TYPE 2 DI...

Patent Expiration Date : 2027-12-03

blank

04

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8222219

Drug Substance Claim :

Drug Product Claim :

Application Number : 204353

Patent Use Code : U-2441

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-11

blank

05

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7943582

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204353

Patent Use Code : U-2441

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-02-26

blank

06

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8222219

Drug Substance Claim :

Drug Product Claim :

Application Number : 204353

Patent Use Code : U-2441

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-11

blank

07

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8222219

Drug Substance Claim :

Drug Product Claim :

Application Number : 204353

Patent Use Code : U-493

Delist Requested :

Patent Use Description : TREATMENT OF TYPE 2 DI...

Patent Expiration Date : 2025-04-11

blank

08

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8513202

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204353

Patent Use Code : U-493

Delist Requested :

Patent Use Description : TREATMENT OF TYPE 2 DI...

Patent Expiration Date : 2027-12-03

blank

09

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7943582

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204353

Patent Use Code : U-493

Delist Requested :

Patent Use Description : TREATMENT OF TYPE 2 DI...

Patent Expiration Date : 2029-02-26

blank

10

arrow
Compamed
Not Confirmed
arrow
Compamed
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8222219

Drug Substance Claim :

Drug Product Claim :

Application Number : 204353

Patent Use Code : U-493

Delist Requested :

Patent Use Description : TREATMENT OF TYPE 2 DI...

Patent Expiration Date : 2025-04-11

blank